Is Aducanumab In Alzheimer’s A Candidate For Medicare ‘Coverage With Evidence Development’?

 
• By Cathy Kelly
Aducanumab Could Set A Precedent For Medicare Coverage Of Alzheimer's Drugs

More from Market Access

More from Pink Sheet